Company Filing History:
3 out of 4 
2 out of 26 
1 out of 19 
Years Active: 1991-2006
Title: The Innovative Contributions of Karoly Albrecht
Introduction
Karoly Albrecht is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of microbiology and pharmaceuticals, holding a total of eight patents. His work primarily focuses on the development of antibiotics and other pharmaceutical compounds.
Latest Patents
Among his latest patents is a process for the preparation of pseudomonic acid A, an antibiotic produced through microbiological methods. This innovative procedure involves the submerged cultivation of a bacterium strain capable of biosynthesizing substantially pure pseudomonic acid A under aerated conditions via fermentation. The process includes the isolation of the desired compound, specifically utilizing the bacterium strain No. 19/26, which is deposited under accession No. NCAIM(P)B 001235 in the National Collection of the Agricultural and Industrial Microorganisms in Budapest, Hungary. The cultivation occurs on a medium at temperatures between 20°C and 30°C, incorporating organic nitrogen and carbon sources, along with optional mineral salts. Another significant patent involves a microbial process for preparing pravastatin, showcasing his expertise in pharmaceutical innovation.
Career Highlights
Karoly Albrecht has worked with esteemed organizations such as the Institute for Drug Research Ltd. and Biogal Gyogyszergyar Rt. His career reflects a commitment to advancing drug research and development, particularly in the area of antibiotic production.
Collaborations
Throughout his career, Albrecht has collaborated with notable colleagues, including Istvan M Szabo and Istvan Barta. These partnerships have contributed to the success of his research and the development of his patented processes.
Conclusion
Karoly Albrecht's contributions to the field of microbiology and pharmaceuticals are significant, with a focus on antibiotic development and innovative processes. His work continues to impact the industry positively, showcasing the importance of research and collaboration in advancing medical science.